➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 27, 2021

DrugPatentWatch Database Preview

Nexgen Pharma Inc Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?

NEXGEN PHARMA INC has thirteen approved drugs.

Summary for Nexgen Pharma Inc

US Patents:	0
Tradenames:	12
Ingredients:	12
NDAs:	13

Drugs and US Patents for Nexgen Pharma Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexgen Pharma Inc	POLYETHYLENE GLYCOL 3350	polyethylene glycol 3350	FOR SOLUTION;ORAL	077706-001	Sep 27, 2006		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Nexgen Pharma Inc	SODIUM PENTOBARBITAL	pentobarbital sodium	TABLET;ORAL	084238-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Nexgen Pharma Inc	FOLIC ACID	folic acid	TABLET;ORAL	084915-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Nexgen Pharma Inc	HYDROCORTISONE	hydrocortisone	TABLET;ORAL	083140-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Nexgen Pharma Inc	MEPROBAMATE	meprobamate	TABLET;ORAL	084589-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Nexgen Pharma Inc	MECLIZINE HYDROCHLORIDE	meclizine hydrochloride	TABLET, CHEWABLE;ORAL	086392-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Nexgen Pharma Inc	PROPOXYPHENE HYDROCHLORIDE	propoxyphene hydrochloride	CAPSULE;ORAL	083185-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Nexgen Pharma Inc

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Colorcon

Johnson and Johnson

Express Scripts

Harvard Business School

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.